BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Topics
»
Disease categories and therapies
» Dermatologic
Dermatologic
RSS
Periostat enters phase III trial for the treatment of rosacea
Aug. 21, 2002
Serono and Genentech sign marketing agreement for Raptiva, formerly Xanelim
Aug. 9, 2002
Inamed acquires rights to botulinum toxin type A
Aug. 8, 2002
Modex advances Allox through early-stage clinical testing
Aug. 7, 2002
Potential use of efalizumab in the treatment of T-cell-mediated diseases
Aug. 6, 2002
GRP promotes keratinocyte proliferation and wound healing in vitro and in vivo
Aug. 5, 2002
Access initiates OraDisc phase III trial, acquires rights to amlexanox
July 26, 2002
Karo Bio to outlicense KB-002611
July 25, 2002
Organogenesis negotiates return of Apligraf rights from Novartis
July 25, 2002
Celltech identifies new inhibitors of LFA-1/ICAM-1 interaction
July 17, 2002
Previous
1
2
…
338
339
340
341
342
343
344
345
346
…
443
444
Next
RSS